News

The Asian MS webinar on the importance of diversity in clinical trials is available to watch now as a recording in your own time! 

New protocol (v6.0) and Participate Quick Guide for participants.

We have now reached 326 participants randomised and 392 participants screened meaning we have recruited 87% of our goal for analysis stage 1 (375)!

We have now reached 302 participants randomised and 370 participants screened meaning we have recruited 81% of our goal for analysis stage 1 (375)!

Click here to read more about OCTOPUS at the MS Frontiers conference in July held at Liverpool.